Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (0QF.D.EB)

Moderna Inc (0QF.D.EB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moderna Inc 325 Binney Street Cambridge MA 02142 USA

P: 617-714-6500

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Key Statistics

Overview:

Market Capitalization, $K 15,288,079
Shares Outstanding, K 390,734
% of Institutional Shareholders 54.32%

Financials:

Annual Sales, $ 1,922 M
Annual Net Income, $ -2,822 M
Last Quarter Sales, $ 676,000 K
Last Quarter Net Income, $ -826,000 K

Growth:

1-Year Return 62.10%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 47.64%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -8.06
Dividend Payout Ratio 0.00%

0QF.D.EB Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.87%
Return-on-Assets % -21.31%
Profit Margin % -146.83%
Debt/Equity 0.15
Price/Sales 10.86
Price/Cash Flow N/A
Price/Book 2.45
Book Value/Share 18.63
Interest Coverage -275.80
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar